1.1 Scope of Research

1.2 Research Methodology

1.2 Research Methodology (continued)

1.3 Emerging Technologies Enabling the Development of Patient Friendly Cardiovascular Diagnostics

2.1 Cardiovascular Diagnostic Devices

2.2 Segmentation Based on Technology

2.3 Segmentation Based on Applications

2.4 Technology Segmentation

2.5 Electrocardiogram (ECG) Devices

2.5.1 Diagnostic ECG devices by GE Healthcare

2.5.2 Diagnostic ECG devices by Philips Healthcare

2.5.3 Intelligent ECG by Cardiolyse-Oxford University Innovation

2.5.4 HeartCheck PEN by CardioComm Solutions, Inc.

2.6 Holter Monitor or Ambulatory Electrocardiography

2.6.1 BodyGuardian® Holter by Preventice Solutions Inc.

2.6.2 Novi patch by The ScottCare Cardiovascular Solutions

2.6.3 Zio Patch by iRhythm Technologies

2.6.4 MomeKardia by InfoBionic Inc.

2.6.5 Kardia by AliveCor, Inc.

2.6.6 Mobile Cardiac Telemetry by LifeWatch AG

2.6.7 Other Technology Innovations in Holter Monitors or Ambulatory Electrocardiography

2.7 Cardiovascular Diagnostic Catheters

2.7.1 Diagnostic Catheters by St. Jude Medical

2.7.2 Diagnostic catheters by Boston Scientific Corp.

2.7.3 Diagnostic catheters by Merit Medical Systems

2.7.4 Other Technology Innovations in Cardiovascular Diagnostic Catheters

2.8 Implantable Loop Recorder/Implantable Cardiac Monitor-

2.8.1 Reveal LINQ Insertable Cardiac Monitor by Medtronic

2.8.2 SJM Confirm™ ICM , by St. Jude Medical

2.8.3 Biomonitor and ProMRI ICD by BIOTRONIK International

2.8.4 Other Innovations in Implantable Cardiac Devices

2.9 Cardiovascular Device Industry Value Chain Analysis

3.1 Impact of Key Drivers–Market and Technology Factors

3.1.1 Ageing Population, Rising Cardiovascular Disease Population Driving the Market Growth

3.1.2 Innovations In Nano and Micro Electro-mechanical Systems Driving the Industry Growth

3.2 Impact of Key Challenges–Market and Technology Factors

3.2.1 Uneven Reimbursement Policies and Market Saturation Challenging the Industry Growth

3.2.2 Inefficient Healthcare Data Management Challenging Industry Growth

3.3 Increasing Industry Funding In Wearable And Wireless And Remote Monitoring Device Companies

3.4 Federal Funding (NIH, USA) Fueling the R&D of Cardiovascular Diagnostics

3.5 Analysis of Strategic Mergers and Acquisitions in Cardiovascular Diagnostic Market, 2015-2016

3.6 Analysis of Strategic Mergers and Acquisitions in Cardiovascular Diagnostic Market, 2014

3.7 Strategic Partnerships and Collaborations for Market Expansion

3.8 Strategic Partnerships and Collaborations to Gain Complementary Technologies

3.9 Upcoming Innovative Cardiovascular Diagnostic Devices in Clinical Trials

4.1 Technologies Poised to Enable Cardiovascular Diagnostics in the Future

4.1.1 Smart Wearables for Mobile Diagnostics and Monitoring

4.1.2 Novel Biosensors for Accurate Diagnostics

4.1.3 Everything-as-a-Service (XaaS) Platform for Connected Health

4.1.4 Predictive Diagnostics Using Predictive Analytics to Alleviate Health Risks and Complications

4.1.5 Lithium Ion Battery Enabling Wireless Patient Monitoring

5.1 Regional Technology Adoption

5.2 Strategic Recommendations Based on Demand Side Analysis

6.1 Top Patent Holders in Cardiovascular Diagnostic Industry

6.2 Steady Increase in Patents Published Over Last Five Years

6.3 USA, followed by China are the Top Source Jurisdiction

6.4 List of Recent Patents in Cardiovascular Diagnostics

6.4 List of Recent Patents in Cardiovascular Diagnostics (continued)

6.4 List of Recent Patents in Cardiovascular Diagnostics (continued)

6.5 List of Key Industry Participants

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy